Company Filing History:

10 out of 42

Celltech Limited

patents

8 out of 81

Celltech Therapeutics Limited

Years Active: 1992-2004

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6774228 - Tetra-aza macrocycles and metal complexes thereof (2004-08-10),

2. 6511663 - Tri- and tetra-valent monospecific antigen-binding proteins (2003-01-28),

3. 6096747 - Phenylaminocarbonyl derivatives and processes for their preparation (2000-08-01),

4. 5889058 - Peptidyl derivatives (1999-03-30),

5. 5827890 - Succinamide derivatives, processes for their preparation and their use (1998-10-27),

6. 5714491 - Peptidyl derivatives as metalloproteinase inhibitors (1998-02-03),

7. 5714149 - Crosslinked antibodies and processes for their preparation (1998-02-03),

8. 5684135 - Conjugate compounds containing aza-macro-cycles and processes for their (1997-11-04),

9. 5569665 - Peptidyl derivatives and their use as metalloproteinases inhibitors (1996-10-29),

10. 5565562 - Triaza macrocycles (1996-10-15),

11. 5550137 - Phenylaminocarbonyl derivatives (1996-08-27),

12. 5530128 - N-sulphonylamino derivatives of dipetide compounds as metalloproteinase (1996-06-25),

13. 5484893 - Tri-aza macrocycles and metal complexes thereof (1996-01-16),

14. 5340827 - Phenylcarboxamide compounds which have useful pharmaceutical activity (1994-08-23),

15. 5300501 - Peptidyl derivatives (1994-04-05),

Title: Thomas A Millican: A Visionary Inventor Pushing the Boundaries of Innovation

Introduction:

Thomas A Millican is a visionary inventor based in Maidenhead, GB, whose passion for innovation and dedication to pushing the boundaries of what is possible have established him as a truly exceptional figure in the field of inventions. With a strong focus on advancing technologies for the betterment of society, Millican's work has garnered recognition on a global scale.

Latest Patents:

Millican's latest patents include groundbreaking inventions such as Tetra-aza macrocycles and metal complexes thereof, which are utilized in the preparation of imaging agents for targeting specific types of tissue. Additionally, his invention of tri- and tetra-valent monospecific antigen-binding proteins has revolutionized the fields of cancer treatment and diagnosis.

Career Highlights:

Throughout his career, Thomas A Millican has accumulated an impressive portfolio of 19 patents, showcasing his innovative prowess and commitment to scientific advancement. His contributions to companies such as Celltech Limited and Celltech Therapeutics Limited have paved the way for cutting-edge developments in the biotechnology sector.

Collaborations:

Millican has collaborated with esteemed professionals in the field, including Nigel Robert Beeley and David Parker, who have played integral roles in the successful implementation of his inventions. Together, they have synergized their expertise to bring revolutionary concepts to fruition, driving progress and innovation in the industry.

Conclusion:

In conclusion, Thomas A Millican stands out as a trailblazing inventor whose relentless pursuit of innovation has led to groundbreaking advancements in the field. His remarkable achievements in patenting novel technologies underscore his commitment to shaping a brighter future through ingenuity and creativity.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.